Belinda Juran's practice focuses on advising clients on technology-centered transactions. She helps biotechnology, pharmaceutical, medical device, high technology and service companies achieve their strategic goals by advising them on all phases of their product development and commercialization relationships. Ms. Juran negotiates and advises clients on collaboration, development, distribution, license and service agreements with customers, suppliers, licensors, licensees and other third parties, and on the acquisition and sale of intellectual property and joint venture arrangements. She works with clients on matters ranging from bet-the-company billion-dollar global strategic collaborations to day-to-day issues. Ms. Juran also has provided general corporate advice to public and private companies and has represented companies in venture capital financings, initial public offerings and mergers and acquisitions. She also works closely with WilmerHale's IP litigation team, negotiating settlement and license agreements to settle ANDA and other litigation matters.
Ms. Juran provides her clients with practical insights by combining her experience and education in technology, business and law. Prior to practicing law, Ms. Juran worked in the high technology industry for several years, where she developed sophisticated computer-aided engineering software, then managed engineering departments. She has also been a consultant to several high technology companies.
Learn more about Ms. Juran's practice and how she can support your startup on WilmerHaleLaunch.com.
Transactions and Licensing
JD, cum laude, Harvard Law School, 1998
MBA, magna cum laude, Boston University, 1995
BS, Mathematics, summa cum laude, University of Scranton, 1981
Honors & Awards
Recommended in the 2016 edition of The Legal 500 United States for her work in M&A/Corporate and Commercial as well as Media, Technology and Telecoms: Outsourcing and Transactions
Named a "Life Sciences Star" in the 2016 edition of LMG Life Sciences for finance and transactional
Recognized by The Legal 500 United States in 2013 as "a fantastic collaborator" and "outstanding in licensing"
LMG Life Sciences selected the firm as winner of its “Canadian Impact Deals of the Year” in 2013 award for its representation of Enobia Pharma in the company's acquisition by Alexion Pharmaceuticals, Inc.
Named to the Women's Business Boston's Top 10 Corporate Lawyers list
Ms. Juran has participated in the M. Ellen Carpenter Financial Literacy Program conducted through the Boston Bar Association.
Ms. Juran sits on the board of directors of UTEC, the United Teen Equality Center of Lowell, Massachusetts. Through job training, education and social support, UTEC enables Lowell's most disconnected young people to trade violence and poverty for social and economic success.
Hartmut Schneider is a US and German-qualified lawyer who practices antitrust law primarily before US agencies and courts. He has extensive experience in securing merger clearance for transactions in a diverse range of industries. He also regularly counsels clients on legal issues at the intersection of antitrust and intellectual property law, as well as on the compliance of joint ventures, other horizontal cooperation agreements and vertical distribution agreements with the antitrust laws.
Before relocating to Washington in 2005, Mr. Schneider worked in the Antitrust and Competition Department of the firm's Brussels and Berlin offices, as well as in the New York office. In addition to his US antitrust law expertise, Mr. Schneider has significant experience in EC and German competition law.
Regulatory and Government Affairs
Antitrust and Competition
European Union Regulatory Group
LLM, University of Michigan Law School, 2000
Second State Exam, Berlin, Court of Appeals, 1999
Doctorate in Law, University of Freiburg, 1997
First State Exam, University of Freiburg, 1996
Licence en droit, University of Paris X - Nanterre, 1993
District of Columbia
Honors & Awards
Selected as a top-rated antitrust litigation lawyer in 2016 by Washington DC Super Lawyers
Recognized in the 2015 and 2016 editions of Global Competition Review's Who's Who Legal, The International Who's Who of Competition Lawyers and Economists
Recognized for antitrust in The Legal 500 (United States) (2012-2016)
Listed in the 2014 edition of Expert Guides as a leading economist in Washington DC in the area of Competition/Antitrust Law
Mr. Schneider currently serves as a Co-Chair of the ABA Section of Antitrust Law's Intellectual Property Committee. Previously, he served as Co-Chair of the Spring Meeting (2013-2015), as a Member of the Section's Long Range Planning and Nominating Committees, and as the Assistant to the Chair of the Section.
Sarah Petty has experience with intellectual property litigation in the ITC, the federal district courts and the Federal Circuit. She has assisted at trial on cases involving smartphone technologies, computer mouse products, digital camera technology, medical devices and patent ownership issues. Ms. Petty handles all aspects of pretrial discovery, motion practice and trial preparation. She has experience taking and defending depositions of fact and expert witnesses; drafting motions and briefs; handling written discovery; preparing witnesses for trial; and conducting trial examinations of witnesses.
In 2011, Ms. Petty served for six months as an Assistant District Attorney for the Commonwealth of Massachusetts. During her time as a prosecutor, she argued dozens of motions and tried ten cases to verdict.
JD, Harvard Law School, 2006
BA, Psychology, magna cum laude, Amherst College, 2001, Phi Beta Kappa
Honors & Awards
Named to the "Top Women Attorneys in Massachusetts Rising Stars" list in the April 2016 and 2017 issues of Boston Magazine
Selected as a "Massachusetts Super Lawyers' 'Rising Star'" in 2013, 2014, 2015 and 2016 in the area of intellectual property litigation